Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
Crossref DOI link: https://doi.org/10.1186/s13550-016-0240-5
Published Online: 2016-11-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chan, Ho Sze
Konijnenberg, Mark W.
Daniels, Tamara
Nysus, Monique
Makvandi, Mehran
de Blois, Erik
Breeman, Wouter A.
Atcher, Robert W.
de Jong, Marion
Norenberg, Jeffrey P.
License valid from 2016-11-21